Pharmaron Beijing forecasts revenue growth despite profit decline

Pharmaron Beijing Co forecasts revenue of 633-650 billion yuan for the first half of 2025, up 13-16% year-on-year.

However, net profit attributable to shareholders is expected to decline 36-39% to 68-71 billion yuan, primarily due to a substantial decrease in non-recurring gains from the prior year.